171 related articles for article (PubMed ID: 23645673)
1. Selective enhancing effect of early mitotic inhibitor 1 (Emi1) depletion on the sensitivity of doxorubicin or X-ray treatment in human cancer cells.
Shimizu N; Nakajima NI; Tsunematsu T; Ogawa I; Kawai H; Hirayama R; Fujimori A; Yamada A; Okayasu R; Ishimaru N; Takata T; Kudo Y
J Biol Chem; 2013 Jun; 288(24):17238-52. PubMed ID: 23645673
[TBL] [Abstract][Full Text] [Related]
2. DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest.
Lee J; Kim JA; Barbier V; Fotedar A; Fotedar R
Mol Biol Cell; 2009 Apr; 20(7):1891-902. PubMed ID: 19211842
[TBL] [Abstract][Full Text] [Related]
3. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation.
Yim H; Erikson RL
Mol Cell Biol; 2009 May; 29(10):2609-21. PubMed ID: 19289504
[TBL] [Abstract][Full Text] [Related]
5. The APC/C inhibitor, Emi1, is essential for prevention of rereplication.
Machida YJ; Dutta A
Genes Dev; 2007 Jan; 21(2):184-94. PubMed ID: 17234884
[TBL] [Abstract][Full Text] [Related]
6. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.
Moshe Y; Boulaire J; Pagano M; Hershko A
Proc Natl Acad Sci U S A; 2004 May; 101(21):7937-42. PubMed ID: 15148369
[TBL] [Abstract][Full Text] [Related]
7. EMI1 switches from being a substrate to an inhibitor of APC/C
Cappell SD; Mark KG; Garbett D; Pack LR; Rape M; Meyer T
Nature; 2018 Jun; 558(7709):313-317. PubMed ID: 29875408
[TBL] [Abstract][Full Text] [Related]
8. Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.
Miller JJ; Summers MK; Hansen DV; Nachury MV; Lehman NL; Loktev A; Jackson PK
Genes Dev; 2006 Sep; 20(17):2410-20. PubMed ID: 16921029
[TBL] [Abstract][Full Text] [Related]
9. FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition.
Yu J; Zhang W; Gao F; Liu YX; Chen ZY; Cheng LY; Xie SF; Zheng SS
Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):184-91. PubMed ID: 24686546
[TBL] [Abstract][Full Text] [Related]
10. Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C.
Di Fiore B; Pines J
J Cell Biol; 2007 May; 177(3):425-37. PubMed ID: 17485488
[TBL] [Abstract][Full Text] [Related]
11. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis.
Ma HT; Tsang YH; Marxer M; Poon RY
Mol Cell Biol; 2009 Dec; 29(24):6500-14. PubMed ID: 19822658
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the action of early mitotic inhibitor 1 on the anaphase-promoting complex/cyclosome by cyclin-dependent kinases.
Moshe Y; Bar-On O; Ganoth D; Hershko A
J Biol Chem; 2011 May; 286(19):16647-57. PubMed ID: 21454540
[TBL] [Abstract][Full Text] [Related]
13. The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers.
Marzio A; Puccini J; Kwon Y; Maverakis NK; Arbini A; Sung P; Bar-Sagi D; Pagano M
Mol Cell; 2019 Jan; 73(2):224-237.e6. PubMed ID: 30554948
[TBL] [Abstract][Full Text] [Related]
14. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.
Chen JY; Wang MC; Hung WC
J Cell Physiol; 2011 Feb; 226(2):407-13. PubMed ID: 20717963
[TBL] [Abstract][Full Text] [Related]
15. Emi1 preferentially inhibits ubiquitin chain elongation by the anaphase-promoting complex.
Wang W; Kirschner MW
Nat Cell Biol; 2013 Jul; 15(7):797-806. PubMed ID: 23708001
[TBL] [Abstract][Full Text] [Related]
16. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex.
Reimann JD; Freed E; Hsu JY; Kramer ER; Peters JM; Jackson PK
Cell; 2001 Jun; 105(5):645-55. PubMed ID: 11389834
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis.
Yu Y; Munger K
Virology; 2013 Nov; 446(1-2):251-9. PubMed ID: 24074588
[TBL] [Abstract][Full Text] [Related]
18. The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma.
McHugh A; Fernandes K; Chinner N; Ibrahim AFM; Garg AK; Boag G; Hepburn LA; Proby CM; Leigh IM; Saville MK
J Invest Dermatol; 2020 Jun; 140(6):1154-1165.e5. PubMed ID: 31705877
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.
Moustafa D; Elwahed MRA; Elsaid HH; Parvin JD
PLoS One; 2021; 16(1):e0235025. PubMed ID: 33412559
[TBL] [Abstract][Full Text] [Related]
20. Rereplication in emi1-deficient zebrafish embryos occurs through a Cdh1-mediated pathway.
Robu ME; Zhang Y; Rhodes J
PLoS One; 2012; 7(10):e47658. PubMed ID: 23082190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
